ASX:COHMedical Equipment
Should Cochlear’s Weaker Profit, Lower Dividend and Soft Outlook Require Action From Cochlear (ASX:COH) Investors?
Cochlear Limited recently reported its full-year 2026 results, with sales of A$2,347.6 million, net income of A$147.3 million, and a lower ordinary dividend of A$1.30 per security for the six months to June 30, 2026.
Alongside modest revenue growth, the sharp reduction in earnings per share and guidance for only low single-digit constant-currency sales growth in fiscal 2027 raises questions about the balance between Cochlear’s innovation spending and its profitability and payout...